Enantiomeric Agonists of the Type 2 Cannabinoid Receptor Reduce Retinal Damage during Proliferative Vitreoretinopathy and Inhibit Hyperactive Microglia <i>In Vitro</i>
A. P. Young(St. Jude Children's Research Hospital), Eileen M. Denovan‐Wright(Dalhousie University)
Cited by 5
Related Papers
No related papers found
Powered by citation graph analysis